Merinum Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 26 Days
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth 92.40%
- Ebitda 92.40%
- Net Worth -19.60%
- Total Assets -16.39%
About Merinum Biotech India
Merinum Biotech India Private Limited (MBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2017 (Eight years 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nishma Dutta, Sanjay Sachdev, and Narinder Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2017PTC310204
-
Company No.
310204
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 2017
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Merinum Biotech India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishma Dutta
|
Director | 03-May-2020 | Current |
|
Sanjay Sachdev
|
Director | 08-Jul-2020 | Current |
|
Narinder Sharma
|
Director | 03-May-2020 | Current |
Financial Performance of Merinum Biotech India.
Merinum Biotech India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 92.4% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merinum Biotech India?
In 2020, Merinum Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Takshashila Home Private Limited (Opc)Nishma Dutta is a mutual person
-
L.A.Garments Private Limited
Sanjay Sachdev is a mutual person
-
Aikyam Resorts Llp
Narinder Sharma is a mutual person
-
Veer Motels & Resorts (P) Ltd.
Narinder Sharma is a mutual person
-
Aikyam Hotels Private Limited
Narinder Sharma is a mutual person
-
Golden Route Hotels Private Limited
Narinder Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Merinum Biotech India?
Unlock and access historical data on people associated with Merinum Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merinum Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merinum Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
